# 129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study

> **NCT04677426** · PHASE2 · WITHDRAWN · sponsor: **University of Kansas Medical Center**

## Conditions studied

- Idiopathic Pulmonary Fibrosis
- Hypersensitivity Pneumonitis

## Interventions

- **DRUG:** Hyperpolarized Xe129

## Key facts

- **NCT ID:** NCT04677426
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-05-01
- **Primary completion:** 2022-08-01
- **Final completion:** 2022-08-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor withdrew Funding
- **Last updated:** 2022-09-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04677426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04677426, "129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04677426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*